Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis
Article in The Lancet Oncology (March 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy
Article in ESMO Open (November 2023)
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients
Article in World Journal of Urology (November 2023)